Tokyo, Feb. 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060596) titled 'A Study to Evaluate the Effectiveness and Safety of Switching to Romosozumab in Patients with Rheumatoid Arthritis and Fragility Fractures' on Feb. 19.
Study Type:
Observational
Primary Sponsor:
Institute - Kawasaki Medical School
Condition:
Condition - Rheumatoid arthritis with fragility fractures
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to evaluate the effectiveness and safety of switching from antiresorptive agents to romosozumab in patients with rheumatoid arthritis and a history of fragility fractures.
Basic objectives2 - S...